163 related articles for article (PubMed ID: 9443401)
1. Mouse models for hereditary nonpolyposis colorectal cancer.
de Wind N; Dekker M; van Rossum A; van der Valk M; te Riele H
Cancer Res; 1998 Jan; 58(2):248-55. PubMed ID: 9443401
[TBL] [Abstract][Full Text] [Related]
2. MSH2 deficiency contributes to accelerated APC-mediated intestinal tumorigenesis.
Reitmair AH; Cai JC; Bjerknes M; Redston M; Cheng H; Pind MT; Hay K; Mitri A; Bapat BV; Mak TW; Gallinger S
Cancer Res; 1996 Jul; 56(13):2922-6. PubMed ID: 8674041
[TBL] [Abstract][Full Text] [Related]
3. Spontaneous and mutagen-induced loss of DNA mismatch repair in Msh2-heterozygous mammalian cells.
Borgdorff V; van Hees-Stuivenberg S; Meijers CM; de Wind N
Mutat Res; 2005 Jul; 574(1-2):50-7. PubMed ID: 15914206
[TBL] [Abstract][Full Text] [Related]
4. Cell lineage-specific effects associated with multiple deficiencies of tumor susceptibility genes in Msh2(-/-)Rb(+/-) mice.
Nikitin AY; Liu CY; Flesken-Nikitin A; Chen CF; Chen PL; Lee WH
Cancer Res; 2002 Sep; 62(18):5134-8. PubMed ID: 12234974
[TBL] [Abstract][Full Text] [Related]
5. Suppression of intestinal polyps in Msh2-deficient and non-Msh2-deficient multiple intestinal neoplasia mice by a specific cyclooxygenase-2 inhibitor and by a dual cyclooxygenase-1/2 inhibitor.
Lal G; Ash C; Hay K; Redston M; Kwong E; Hancock B; Mak T; Kargman S; Evans JF; Gallinger S
Cancer Res; 2001 Aug; 61(16):6131-6. PubMed ID: 11507063
[TBL] [Abstract][Full Text] [Related]
6. Suppression of intestinal and mammary neoplasia by lifetime administration of aspirin in Apc(Min/+) and Apc(Min/+), Msh2(-/-) mice.
Sansom OJ; Stark LA; Dunlop MG; Clarke AR
Cancer Res; 2001 Oct; 61(19):7060-4. PubMed ID: 11585736
[TBL] [Abstract][Full Text] [Related]
7. No evidence for dual role of loss of heterozygosity in hereditary non-polyposis colorectal cancer.
Tuupanen S; Karhu A; Järvinen H; Mecklin JP; Launonen V; Aaltonen LA
Oncogene; 2007 Apr; 26(17):2513-7. PubMed ID: 17043646
[TBL] [Abstract][Full Text] [Related]
8. Two mismatch repair gene mutations found in a colon cancer patient--which one is pathogenic?
Kariola R; Otway R; Lönnqvist KE; Raevaara TE; Macrae F; Vos YJ; Kohonen-Corish M; Hofstra RM; Nyström-Lahti M
Hum Genet; 2003 Feb; 112(2):105-9. PubMed ID: 12522549
[TBL] [Abstract][Full Text] [Related]
9. Functional analysis of HNPCC-related missense mutations in MSH2.
Lützen A; de Wind N; Georgijevic D; Nielsen FC; Rasmussen LJ
Mutat Res; 2008 Oct; 645(1-2):44-55. PubMed ID: 18822302
[TBL] [Abstract][Full Text] [Related]
10. Multiple epithelial and nonepithelial tumors in hereditary nonpolyposis colorectal cancer: characterization of germline and somatic mutations of the MSH2 gene and heterogeneity of replication error phenotypes.
Huang RL; Chao CF; Ding DC; Yu CP; Chang CC; Lai HC; Yu MH; Liu HS; Chu TY
Cancer Genet Cytogenet; 2004 Sep; 153(2):108-14. PubMed ID: 15350299
[TBL] [Abstract][Full Text] [Related]
11. A novel germline mutation of MSH2 in a hereditary nonpolyposis colorectal cancer patient with liposarcoma.
Hirata K; Kanemitsu S; Nakayama Y; Nagata N; Itoh H; Ohnishi H; Ishikawa H; Furukawa Y;
Am J Gastroenterol; 2006 Jan; 101(1):193-6. PubMed ID: 16405554
[TBL] [Abstract][Full Text] [Related]
12. Spontaneous intestinal carcinomas and skin neoplasms in Msh2-deficient mice.
Reitmair AH; Redston M; Cai JC; Chuang TC; Bjerknes M; Cheng H; Hay K; Gallinger S; Bapat B; Mak TW
Cancer Res; 1996 Aug; 56(16):3842-9. PubMed ID: 8706033
[TBL] [Abstract][Full Text] [Related]
13. A 10-Mb paracentric inversion of chromosome arm 2p inactivates MSH2 and is responsible for hereditary nonpolyposis colorectal cancer in a North-American kindred.
Wagner A; van der Klift H; Franken P; Wijnen J; Breukel C; Bezrookove V; Smits R; Kinarsky Y; Barrows A; Franklin B; Lynch J; Lynch H; Fodde R
Genes Chromosomes Cancer; 2002 Sep; 35(1):49-57. PubMed ID: 12203789
[TBL] [Abstract][Full Text] [Related]
14. Evidence for Msh2 haploinsufficiency in mice revealed by MNU-induced sister-chromatid exchange analysis.
Bouffler SD; Hofland N; Cox R; Fodde R
Br J Cancer; 2000 Nov; 83(10):1291-4. PubMed ID: 11044352
[TBL] [Abstract][Full Text] [Related]
15. Non-Hodgkin lymphoma related to hereditary nonpolyposis colorectal cancer in a patient with a novel heterozygous complex deletion in the MSH2 gene.
Pineda M; Castellsagué E; Musulén E; Llort G; Frebourg T; Baert-Desurmont S; González S; Capellá G; Blanco I
Genes Chromosomes Cancer; 2008 Apr; 47(4):326-32. PubMed ID: 18181177
[TBL] [Abstract][Full Text] [Related]
16. Frequent mutation of beta-catenin and APC genes in primary colorectal tumors from patients with hereditary nonpolyposis colorectal cancer.
Miyaki M; Iijima T; Kimura J; Yasuno M; Mori T; Hayashi Y; Koike M; Shitara N; Iwama T; Kuroki T
Cancer Res; 1999 Sep; 59(18):4506-9. PubMed ID: 10493496
[TBL] [Abstract][Full Text] [Related]
17. Loss of DNA mismatch repair function and cancer predisposition in the mouse: animal models for human hereditary nonpolyposis colorectal cancer.
Edelmann L; Edelmann W
Am J Med Genet C Semin Med Genet; 2004 Aug; 129C(1):91-9. PubMed ID: 15264277
[TBL] [Abstract][Full Text] [Related]
18. The associated contributions of p53 and the DNA mismatch repair protein Msh6 to spontaneous tumorigenesis.
Young LC; Keuling AM; Lai R; Nation PN; Tron VA; Andrew SE
Carcinogenesis; 2007 Oct; 28(10):2131-8. PubMed ID: 17615258
[TBL] [Abstract][Full Text] [Related]
19. Novel germline mutation (300-305delAGTTGA) in the human MSH2 gene in hereditary non-polyposis colorectal cancer (HNPCC).
Glasl S; Papatheodorou L; Baretton G; Jung C; Gross M
Hum Mutat; 2000 Jul; 16(1):91-2. PubMed ID: 10874318
[TBL] [Abstract][Full Text] [Related]
20. Chemopreventive effects of dietary folate on intestinal polyps in Apc+/-Msh2-/- mice.
Song J; Sohn KJ; Medline A; Ash C; Gallinger S; Kim YI
Cancer Res; 2000 Jun; 60(12):3191-9. PubMed ID: 10866310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
